Research progress on the economic toxicity in patients with chronic diseases

Abstract

Abstract: Chronic diseases have the characteristics of long duration of disease,low cure rate,easy recurrence,etc.,which will make patients in a state of high expenditure and low income for a long time,aggravate economic toxicity and seriously reduce the quality of life. This article reviews the relevant studies and intervention measures of economic toxicity in patients with chronic diseases,and provide references for optimizing nursing decisions to improve patients' treatment compliance and reduce the adverse effects of economic toxicity.

Key words: Chronic diseases, Economic toxicity, Research progress

CLC Number:

R181.3⁺9

LONG Liyuan, LI Yuan, FENG Siyi, FANG Jinbo. Research progress on the economic toxicity in patients with chronic diseases. [J]OCCUPATION AND HEALTH, 2024, 40(23): 3302-3307.

References

[1] GBD 2019 Diseases and Injuries Collaborators.Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:A systematic analysis for the Global Burden of Disease Study 2019BD 2019 Diseases and Injuries Collaborators.Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:A systematic analysis for the Global Burden of Disease Study 2019[J].Lancet,2020,396(10258):1204-1222.
[2] 齐元涛,柳言,杜金,等.基于健康生态学模型的我国老年人慢性病共病影响因素研究[J].中国全科医学,2023,26(1):50-57.
[3] 解垩. 中国居民慢性病的经济影响[J].世界经济文汇,2011(3):74-86.
[4] ZAFAR S Y,PEPPERCORN J M,SCHRAG D,et al.The financial toxicity of cancer treatment:a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience[J].The Oncologist,2013, 18(4):381-390.
[5] CARRERA P M,KANTARJIAN H M,BLINDER V S.The financial burden and distress of patients with cancer:Understanding and stepping-up action on the financial toxicity of cancer treatment[J].CA Cancer J Clin,2018,68(2):153-165.
[6] De SOUZA J A,YAP B J,WROBLEWSKI K,et al.Measuring financial toxicity as a clinically relevant patient-reported outcome:The validation of the COmprehensive Score for financial Toxicity(COST)[J].Cancer,2017, 123(3):476-484.
[7] 于慧会,毕雪,刘运泳.中文版癌症患者报告结局的经济毒性量表信度和效度研究[J].中华流行病学杂志,2017,38(8):1118-1120.
[8] CHAN D N S,CHOI K C,NG M S N,et al.Translation and validation of the Traditional Chinese version of the COmprehensive Score for financial Toxicity-Functional Assessment of Chronic Illness Therapy(Version 2)[J].Health Qual Life Outcomes,2021,19(1):17.
[9] 戈映雪,刘慧妮,江鑫,等.乳腺癌患者经济毒性体验的纵向质性研究[J].心理月刊,2023,18(10):13-16.
[10] PATEL M R,ZHANG G,HEISLER M,et al.Measurement and Validation of the Comprehensive Score for Financial Toxicity(COST) in a Population With Diabetes[J].Diabetes Care,2022,45(11):2535-2543.
[11] DING R,MORVIL G,GOH B B G,et al.Perception of disease,well-being and financial burden by patients with chronic hepatitis B:A self-reported assessment[J].Ann Acad Med Singap,2022,51(6):378-380.
[12] 王咪,林征,周美景,等.炎症性肠病患者经济毒性的研究进展[J].中华现代护理杂志,2022,28(12):1667-1671.
[13] HUENIKEN K,DOUGLAS C M,JETHWA A R,et al.Measuring financial toxicity incurred after treatment of head and neck cancer:Development and validation of the Financial Index of Toxicity questionnaire[J].Cancer,2020,126(17):4042-4050.
[14] KHERA N.Reporting and grading financial toxicity[J].J Clin Oncol,2014,32(29):3337-3338.
[15] WITTE J,MEHLIS K,SURMANN B,et al.Methods for measuring financial toxicity after cancer diagnosis and treatment:A systematic review and its implications[J].Ann Oncol,2019,30(7):1061-1070.
[16] GIVEN B A,GIVEN C W,STOMMEL M.Family and out-of-pocket costs for women with breast cancer[J].Cancer Practice,1994,2(3):187-193.
[17] 姜华,吕俭霞,牟文轩,等.头颈部肿瘤病人经济毒性指数问卷的汉化及信效度检验[J].护理研究,2023,37(10):1734-1737.
[18] 姜男,白锦兵,魏思琪,等.癌症患者经济毒性的影响因素及管理策略研究进展[J].解放军护理杂志,2020,37(9):62-64.
[19] DEAN L T,MOSS S L,ROLLINSON S I,et al.Patient recommendations for reducing long-lasting economic burden after breast cancer[J].Cancer,2019,125(11):1929-1940.
[20] ESSELEN K M,GOMPERS A,HACKER M R,et al.Evaluating meaningful levels of financial toxicity in gynecologic cancers[J].Int J Gynecol Cancer,2021,31(6):801-806.
[21] SCHOLES-ROBERTSON N,BLAZEK K,TONG A,et al.Financial toxicity experienced by rural Australian families with chronic kidney disease[J].Nephrology(Carlton,Vic.),2023,28(8):456-466.
[22] VALERO-ELIZONDO J,CHOUAIRI F,KHERA R,et al.Atherosclerotic Cardiovascular Disease,Cancer,and Financial Toxicity Among Adults in the United States[J].JACC Cardio Oncology,2021,3(2):236-246.
[23] ILONZE O,FREE K,BREATHETT K.Unequitable Heart Failure Therapy for Black,Hispanic and American-Indian Patients[J].Card Fail Rev,2022,8:e25.
[24] BLOOMFELD R S,BICKSTON S J.Financial toxicity in people with inflammatory bowel disease[J].Inflamm Bowel Dis,2021,27(7):1170-1171.
[25] WANG S Y,VALERO-ELIZONDO J,ALI H-J,et al.Out-of-pocket annual health expenditures and financial toxicity from healthcare costs in patients with heart failure in the united states[J].J Am Heart Assoc,2021,10(14):e022164.
[26] 明玥,王乾沙,黄蓉蓉,等.慢性伤口病人经济毒性研究进展[J].循证护理,2024,10(1):71-74.
[27] 赵凌,陈希伟,庞兆烽,等.维持性血液透析患者经济毒性现状及影响因素的研究[J].临床护理杂志,2023,22(1):6-10.
[28] 张译友,田媛,帕孜来提·赛登,等.脑卒中患者经济毒性现状及影响因素分析[J].中国临床护理,2023,15(3):183-186.
[29] 孙艳玲,况艺,袁潇逸,等.癌症生存者经济毒性现状及影响因素[J].护理学杂志,2022,37(15):24-27,31.
[30] 杨义,褚万立,冯光,等.2 997例皮肤软组织损伤住院患者的回顾性分析[J].中华烧伤杂志,2020,36(9):821-829.
[31] CARRERA P M,KANTARJIAN H M,BLINDER V S.The financial burden and distress of patients with cancer:Understanding and stepping-up action on the financial toxicity of cancer treatment[J].CA Cancer J Clin,2018,68(2):153-165.
[32] UBEL P A,ABERNETHY A P,ZAFAR S Y.Full disclosure--out-of-pocket costs as side effects[J].N Engl J Med,2013,369(16):1484-1486.
[33] ZAFAR S Y,ABERNETHY A P.Financial toxicity,Part I:A new name for a growing problem[J].Oncology(Williston Park),2013,27(2):80-81,149.
[34] GUNN A H,WARRAICH H J,MENTZ R J.Costs of care and financial hardship among patients with heart failure[J].Am Heart J,2023,269:94-107.
[35] HEIDENREICH P A,FONAROW G C,OPSHA Y,et al.Economic issues in heart failure in the united states[J].J Card Fail,2022,28(3):453-466.
[36] ABRAMS H R,DURBIN S,HUANG C X,et al.Financial toxicity in cancer care:Origins,impact,and solutions[J].Transl Behav Med,2021, 11(11):2043-2054.
[37] LAUZIER S,LÉVESQUE P,MONDOR M,et al.Out-of-pocket costs in the year after early breast cancer among Canadian women and spouses[J].J Natl Cancer Inst,2013,105(4):280-292.
[38] 肖德明,林婵兰,张树英,等.慢性心力衰竭患者经济负担调查及规范化治疗对经济负担的影响[J].中国基层医药,2009,16(1):127-128.
[39] YABROFF K R,DOWLING E C,GUY G P,et al.Financial hardship associated with cancer in the united states:Findings from a population-based sample of adult cancer survivors[J].J Clin Oncol,2016, 34(3):259-267.
[40] PDQ Adult Treatment Editorial Board.Financial Toxicity and Cancer Treatment(PDQ<inline-graphic xlink:href="-40-23-3302/img_1.jpg"/>):Health Professional Version[A].PDQ Cancer Information Summaries[M].Bethesda(MD):National Cancer Institute(US),2002.
[41] ZAWUDIE A B,DAKA D W,TESHOME D,et al.Economic burden of diabetic mellitus among patients on follow-up care in hospitals of southwest shewa zone,central ethiopia[J].BMC health Serv Res,2022, 22(1):1398.
[42] STEWART S,HOROWITZ J D.Specialist nurse management programmes:Economic benefits in the management of heart failure[J].Pharmacoeconomics,2003,21(4):225-240.
[43] 赵钦风,李佳婧,焦晨,等.慢性病患者家庭发生灾难性卫生支出研究[J].卫生经济研究,2021,38(2):7-10.
[44] 王龙安,李鑫,李长乐,等.基本医疗保险制度对改善家庭灾难性卫生支出的效果研究[J].经济师,2020(4):58-59.
[45] SUKUMAR S,WASFY J H,JANUZZI J L,et al.Financial toxicity of medical management of heart failure:Jacc review topic of the week[J].J Am Coll Cardiol,2023,81(20):2043-2055.
[46] SMITH G L,BANEGAS M P,ACQUATI C,et al.Navigating financial toxicity in patients with cancer:A Multidisciplinary management approach[J].CA Cancer J Clin,2022,72(5):437-453.
[47] HAMEL L M,DOUGHERTY D W,KIM S,et al.DISCO App:Study protocol for a randomized controlled trial to test the effectiveness of a patient intervention to reduce the financial burden of cancer in a diverse patient population[J].Trials,2021,22(1):636.
[48] WHEELER S B,BIDDELL C B,MANNING M L,et al.Lessening the Impact of Financial Toxicity(LIFT):A protocol for a multi-site,single-arm trial examining the effect of financial navigation on financial toxicity in adult patients with cancer in rural and non-rural settings[J].Trials,2022,23(1):839.
[49] 王正君,司峰,周郁秋,等.财务导航模式在癌症患者中的应用进展[J].军事护理,2023,40(12):81-84.
[50] CHUBAK J,HAWKES R,DUDZIK C,et al.Pilot Study of Therapy Dog Visits for Inpatient Youth With Cancer[J].J Pediatr Oncol Nurs,2017,34(5):331-341.
[51] MADORE S,KILBOURN K,VALVERDE P,et al.Feasibility of a psychosocial and patient navigation intervention to improve access to treatment among underserved breast cancer patients[J].Support Care Cancer,2014,22(8):2085-2093.
[52] KIRCHER S M,YARBER J,RUTSOHN J,et al.Piloting a financial counseling intervention for patients with cancer receiving chemotherapy[J].J Oncol Pract,2019,15(3):e202-e210.
[53] RAO B R,DICKERT N W,MORRIS A A,et al.Heart failure and shared decision-making:Patients open to medication-related cost discussions[J].Circ Heart Fail,2020,13(11):e007094.
[54] PIAMJARIYAKUL U,SMITH C E,WERKOWITCH M,et al.Designing and testing an end-of-life discussion intervention for african american patients with heart failure and their families[J].J Hosp Palliat Nurs,2016,18(6):528.
[55] THOMSON M C,ALLEN L A,HALPERN S D,et al.Framing benefits in decision aids:Effects of varying contextualizing statements on decisions about sacubitril-valsartan for heart failure[J].MDM Policy Pract, 2021,6(2):23814683211041623.
[56] WARRAICH H J,ALI H J R,NASIR K.Financial toxicity with cardiovascular disease management:A balancing act for patients[J].Circ Cardiovasc Qual Outcomes,2020,13(12):e007449.
[57] DICKERT N W,MITCHELL A R,VENECHUK G E,et al.Show me the money:Patients' perspectives on a decision aid for sacubitril/valsartan addressing out-of-pocket cost[J].Circ Cardiovasc Qual Outcomes, 2020, 13(12):e007070.
[58] THAKER D A,MONYPENNY R,OLVER I,et al.Cost savings from a telemedicine model of care in northern Queensland,Australia[J].Med J Aust,2013,199(6):414-417.
[59] BIDDELL C B,KASOW K A,KILLELA M K,et al.Understanding the financial and psychological impact of employment disruption among caregivers of pediatric HSCT recipients:A mixed methods analysis[J].Support Care Cancer,2022,30(6):4747-4757.
[60] LONGACRE M L,WEBER-RALEY L,KENT E E.Cancer caregiving while employed:Caregiving roles,employment adjustments,employer assistance,and preferences for support[J].J Cancer Educ,2021,36(5):920-932.